Aldeyra Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aldeyra Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Aldeyra Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $330K, a 412% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $330K +$266K +412% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $392K +$264K +207% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $452K +$263K +139% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $511K +$262K +105% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $64.5K -$117K -64.6% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $127K -$112K -46.9% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $189K -$107K -36.2% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $249K -$103K -29.2% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $182K -$224K -55.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $240K +$121K +103% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $297K +$121K +68.8% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $352K +$119K +50.8% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $406K +$354K +678% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $118K +$15.3K +14.9% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $176K +$23K +15% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $233K +$32.3K +16.1% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $52.2K -$196K -79% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $103K -$191K -65% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $153K -$225K -59.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $201K Dec 31, 2019 10-K 2021-03-11
Q3 2019 $248K Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $294K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $378K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.